IMP Diagnostics participated in the 3rd National Congress on Gynecology in General and Family Medicine, an important scientific meeting dedicated to strengthening collaboration between gynecologists and primary care physicians. Under the theme “From Menarche to Menopause”, the congress addressed key aspects of women’s health throughout the different stages of life, promoting evidence-based approaches to prevention, diagnosis, and patient management. The event brought together healthcare professionals from across the country, creating an environment for scientific discussion, professional development, and the exchange of clinical experience.
The congress provided an excellent opportunity for IMP Diagnostics to share its expertise in gynecological pathology, molecular diagnostics, cervical cancer screening, HPV testing, and women’s health. As a laboratory with a dedicated Gynecological Pathology Unit, IMP Diagnostics supports healthcare professionals with specialized diagnostic services that contribute to the early detection and accurate characterization of gynecological diseases.
Participation in scientific events such as this reflects the company’s commitment to continuous medical education, innovation, and collaboration with healthcare professionals. The congress also enabled meaningful discussions on emerging challenges in women’s healthcare, including preventive medicine, reproductive health, menopause management, and the integration of new diagnostic technologies into clinical practice. By maintaining a strong presence in multidisciplinary scientific forums, IMP Diagnostics continues to support the advancement of women’s health and the delivery of high-quality patient care.
Events dedicated to gynecology and family medicine play a crucial role in promoting closer cooperation between primary and specialized healthcare services. This collaboration is essential for improving patient pathways, facilitating earlier diagnoses, and ensuring that women receive comprehensive and coordinated care throughout their lives. Through its participation, IMP Diagnostics reinforces its mission of combining scientific excellence, diagnostic innovation, and clinical partnership to contribute to better healthcare outcomes and the future development of women’s health services.